NVO

Recent Articles

3 Big Pharma Stocks Under Pressure From Washington

We cover the technical condition of three Big Pharma stocks, with the help of Profit Scanner, to determine where their prices may be headed. More 

7 Healthcare Stocks That Are Investor Poison

You can't blindly buy stocks in healthcare because there are some that have some serious problems. More 

5 Pharmaceuticals Stocks to Sell Now

The ratings of 5 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

14 Pharmaceuticals Stocks to Sell Now

The overall ratings of 14 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

12 Pharmaceuticals Stocks to Sell Now

This week, the overall grades of 12 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

9 Pharmaceuticals Stocks to Sell Now

This week, 9 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

Why American Airlines Group Inc (AAL), Novo Nordisk A/S (ADR) (NVO) and Synchrony Financial (SYF) Are 3 of Today’s Worst Stocks

American Airlines (AAL), Novo Nordisk (NVO) and Synchrony Financial (SYF) couldn't win for losing on Tuesday. Here's the deal. More